nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—CYP3A4—Temozolomide—skin cancer	0.159	0.233	CbGbCtD
Sertindole—CYP3A4—Imiquimod—skin cancer	0.159	0.233	CbGbCtD
Sertindole—CYP2D6—Vemurafenib—skin cancer	0.137	0.201	CbGbCtD
Sertindole—CYP3A4—Vismodegib—skin cancer	0.11	0.162	CbGbCtD
Sertindole—CYP3A4—Vemurafenib—skin cancer	0.0869	0.128	CbGbCtD
Sertindole—CYP3A4—Docetaxel—skin cancer	0.0298	0.0438	CbGbCtD
Sertindole—HRH1—nose—skin cancer	0.0186	0.109	CbGeAlD
Sertindole—HTR2A—hindlimb—skin cancer	0.00733	0.0428	CbGeAlD
Sertindole—HTR1B—blood vessel—skin cancer	0.00728	0.0425	CbGeAlD
Sertindole—HTR1D—blood vessel—skin cancer	0.00704	0.0412	CbGeAlD
Sertindole—DRD2—nerve—skin cancer	0.00676	0.0395	CbGeAlD
Sertindole—HTR2A—appendage—skin cancer	0.00629	0.0367	CbGeAlD
Sertindole—HTR1F—head—skin cancer	0.00536	0.0314	CbGeAlD
Sertindole—HTR1E—head—skin cancer	0.00465	0.0272	CbGeAlD
Sertindole—ADRA1D—epithelium—skin cancer	0.00459	0.0268	CbGeAlD
Sertindole—HTR2A—nerve—skin cancer	0.00446	0.026	CbGeAlD
Sertindole—HTR2A—endothelium—skin cancer	0.00379	0.0222	CbGeAlD
Sertindole—DRD3—head—skin cancer	0.00379	0.0221	CbGeAlD
Sertindole—KCNH2—nipple—skin cancer	0.00378	0.0221	CbGeAlD
Sertindole—HTR6—head—skin cancer	0.00365	0.0213	CbGeAlD
Sertindole—HTR1D—connective tissue—skin cancer	0.00361	0.0211	CbGeAlD
Sertindole—HTR2A—blood vessel—skin cancer	0.0035	0.0205	CbGeAlD
Sertindole—ADRA1D—female reproductive system—skin cancer	0.00341	0.0199	CbGeAlD
Sertindole—HRH1—nipple—skin cancer	0.00303	0.0177	CbGeAlD
Sertindole—ADRA2A—nipple—skin cancer	0.00298	0.0174	CbGeAlD
Sertindole—ADRA1B—head—skin cancer	0.00291	0.017	CbGeAlD
Sertindole—ADRA1D—head—skin cancer	0.00285	0.0166	CbGeAlD
Sertindole—ADRA1A—epithelium—skin cancer	0.00263	0.0154	CbGeAlD
Sertindole—HTR1B—female reproductive system—skin cancer	0.00263	0.0154	CbGeAlD
Sertindole—HTR1D—female reproductive system—skin cancer	0.00255	0.0149	CbGeAlD
Sertindole—HTR2C—female reproductive system—skin cancer	0.00252	0.0147	CbGeAlD
Sertindole—HTR2A—neck—skin cancer	0.0025	0.0146	CbGeAlD
Sertindole—SLC6A4—female reproductive system—skin cancer	0.00239	0.014	CbGeAlD
Sertindole—HTR1B—head—skin cancer	0.0022	0.0128	CbGeAlD
Sertindole—HRH1—connective tissue—skin cancer	0.00215	0.0126	CbGeAlD
Sertindole—HTR1D—head—skin cancer	0.00213	0.0124	CbGeAlD
Sertindole—ADRA2A—connective tissue—skin cancer	0.00211	0.0123	CbGeAlD
Sertindole—HTR2C—head—skin cancer	0.00211	0.0123	CbGeAlD
Sertindole—HRH1—epithelium—skin cancer	0.00204	0.0119	CbGeAlD
Sertindole—ADRA1A—lymphoid tissue—skin cancer	0.00203	0.0119	CbGeAlD
Sertindole—SLC6A4—head—skin cancer	0.002	0.0117	CbGeAlD
Sertindole—KCNH2—female reproductive system—skin cancer	0.00189	0.011	CbGeAlD
Sertindole—HTR2A—connective tissue—skin cancer	0.00179	0.0105	CbGeAlD
Sertindole—HTR1A—head—skin cancer	0.00177	0.0104	CbGeAlD
Sertindole—HRH1—mammalian vulva—skin cancer	0.00177	0.0103	CbGeAlD
Sertindole—ADRA2A—mammalian vulva—skin cancer	0.00174	0.0102	CbGeAlD
Sertindole—HTR2A—epithelium—skin cancer	0.0017	0.00996	CbGeAlD
Sertindole—ADRA1A—head—skin cancer	0.00164	0.00956	CbGeAlD
Sertindole—DRD2—head—skin cancer	0.0016	0.00937	CbGeAlD
Sertindole—KCNH2—head—skin cancer	0.00158	0.00923	CbGeAlD
Sertindole—HRH1—female reproductive system—skin cancer	0.00152	0.00886	CbGeAlD
Sertindole—ADRA2A—female reproductive system—skin cancer	0.00149	0.0087	CbGeAlD
Sertindole—HRH1—head—skin cancer	0.00127	0.0074	CbGeAlD
Sertindole—HTR2A—female reproductive system—skin cancer	0.00127	0.0074	CbGeAlD
Sertindole—ADRA2A—head—skin cancer	0.00124	0.00727	CbGeAlD
Sertindole—CYP3A4—female reproductive system—skin cancer	0.00117	0.00685	CbGeAlD
Sertindole—CYP2D6—female reproductive system—skin cancer	0.00115	0.00674	CbGeAlD
Sertindole—KCNH2—lymph node—skin cancer	0.00111	0.00646	CbGeAlD
Sertindole—HTR2A—head—skin cancer	0.00106	0.00618	CbGeAlD
Sertindole—CYP2D6—head—skin cancer	0.000963	0.00563	CbGeAlD
Sertindole—HRH1—lymph node—skin cancer	0.000886	0.00518	CbGeAlD
Sertindole—ADRA2A—lymph node—skin cancer	0.000871	0.00509	CbGeAlD
Sertindole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	8.04e-05	0.000543	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—FOXO4—skin cancer	8.01e-05	0.000541	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—SUFU—skin cancer	7.83e-05	0.00053	CbGpPWpGaD
Sertindole—DRD2—Circadian rythm related genes—IL6—skin cancer	7.82e-05	0.000528	CbGpPWpGaD
Sertindole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	7.62e-05	0.000515	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—SHH—skin cancer	7.6e-05	0.000514	CbGpPWpGaD
Sertindole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	7.6e-05	0.000514	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—SHH—skin cancer	7.56e-05	0.000511	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—RASA1—skin cancer	7.55e-05	0.000511	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—RASA1—skin cancer	7.52e-05	0.000508	CbGpPWpGaD
Sertindole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	7.46e-05	0.000504	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—NRAS—skin cancer	7.31e-05	0.000494	CbGpPWpGaD
Sertindole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.29e-05	0.000493	CbGpPWpGaD
Sertindole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.27e-05	0.000492	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—SHH—skin cancer	7.24e-05	0.000489	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PTCH1—skin cancer	7.21e-05	0.000487	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—SMO—skin cancer	7.21e-05	0.000487	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—RASA1—skin cancer	7.19e-05	0.000486	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—SMO—skin cancer	7.17e-05	0.000485	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PTCH1—skin cancer	7.17e-05	0.000485	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—ENO2—skin cancer	7.15e-05	0.000483	CbGpPWpGaD
Sertindole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.14e-05	0.000482	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—FOXO4—skin cancer	7.11e-05	0.000481	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—FOXO4—skin cancer	7.11e-05	0.000481	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PTGER4—skin cancer	7.02e-05	0.000474	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PTGER4—skin cancer	6.98e-05	0.000472	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—NRAS—skin cancer	6.9e-05	0.000466	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—BRAF—skin cancer	6.87e-05	0.000464	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—SMO—skin cancer	6.86e-05	0.000464	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PTCH1—skin cancer	6.86e-05	0.000464	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CSPG4—skin cancer	6.85e-05	0.000463	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PTGER4—skin cancer	6.68e-05	0.000452	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—SHH—skin cancer	6.67e-05	0.000451	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—RASA1—skin cancer	6.63e-05	0.000448	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—SHH—skin cancer	6.57e-05	0.000444	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—SHH—skin cancer	6.55e-05	0.000443	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—RASA1—skin cancer	6.53e-05	0.000441	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—RASA1—skin cancer	6.51e-05	0.00044	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—BRAF—skin cancer	6.48e-05	0.000438	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—SHH—skin cancer	6.43e-05	0.000435	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—RASA1—skin cancer	6.39e-05	0.000432	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PTCH1—skin cancer	6.33e-05	0.000428	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—SMO—skin cancer	6.33e-05	0.000428	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—KRAS—skin cancer	6.29e-05	0.000425	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—SMO—skin cancer	6.23e-05	0.000421	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PTCH1—skin cancer	6.23e-05	0.000421	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—SMO—skin cancer	6.21e-05	0.00042	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PTCH1—skin cancer	6.21e-05	0.00042	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—FOXO4—skin cancer	6.2e-05	0.000419	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—FOXO4—skin cancer	6.17e-05	0.000417	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PTGER4—skin cancer	6.16e-05	0.000416	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PTCH1—skin cancer	6.1e-05	0.000412	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—SMO—skin cancer	6.1e-05	0.000412	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PTGER4—skin cancer	6.06e-05	0.00041	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PTGER4—skin cancer	6.05e-05	0.000409	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—SHH—skin cancer	5.97e-05	0.000404	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—RASA1—skin cancer	5.94e-05	0.000401	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—KRAS—skin cancer	5.94e-05	0.000401	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PTGER4—skin cancer	5.93e-05	0.000401	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—FOXO4—skin cancer	5.9e-05	0.000399	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PTCH1—skin cancer	5.66e-05	0.000383	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—SMO—skin cancer	5.66e-05	0.000383	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TERT—skin cancer	5.59e-05	0.000378	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PLIN2—skin cancer	5.56e-05	0.000376	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TERT—skin cancer	5.55e-05	0.000375	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PTGER4—skin cancer	5.51e-05	0.000373	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—FOXO4—skin cancer	5.44e-05	0.000368	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TERT—skin cancer	5.43e-05	0.000367	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—FOXO4—skin cancer	5.35e-05	0.000362	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—HRAS—skin cancer	5.35e-05	0.000361	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TERT—skin cancer	5.35e-05	0.000361	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—FOXO4—skin cancer	5.34e-05	0.000361	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—FOXO4—skin cancer	5.24e-05	0.000354	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—IL6—skin cancer	5.12e-05	0.000346	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—HRAS—skin cancer	5.05e-05	0.000341	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—FOXO4—skin cancer	4.87e-05	0.000329	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—IL6—skin cancer	4.83e-05	0.000326	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—NRAS—skin cancer	4.78e-05	0.000323	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TERT—skin cancer	4.75e-05	0.000321	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TERT—skin cancer	4.75e-05	0.000321	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—NRAS—skin cancer	4.71e-05	0.000318	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—NRAS—skin cancer	4.68e-05	0.000316	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—ENO2—skin cancer	4.66e-05	0.000315	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—NRAS—skin cancer	4.58e-05	0.000309	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—NRAS—skin cancer	4.5e-05	0.000304	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CSPG4—skin cancer	4.48e-05	0.000303	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—BRAF—skin cancer	4.43e-05	0.000299	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—BRAF—skin cancer	4.39e-05	0.000297	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—NRAS—skin cancer	4.32e-05	0.000292	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—BRAF—skin cancer	4.3e-05	0.000291	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—BRAF—skin cancer	4.23e-05	0.000286	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—ERCC2—skin cancer	4.15e-05	0.000281	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TERT—skin cancer	4.14e-05	0.00028	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TERT—skin cancer	4.12e-05	0.000278	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—KRAS—skin cancer	4.11e-05	0.000278	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—NRAS—skin cancer	4.07e-05	0.000275	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—KRAS—skin cancer	4.05e-05	0.000274	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—KRAS—skin cancer	4.02e-05	0.000272	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—NRAS—skin cancer	4e-05	0.00027	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—NRAS—skin cancer	4e-05	0.00027	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TERT—skin cancer	3.94e-05	0.000266	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—KRAS—skin cancer	3.94e-05	0.000266	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—KRAS—skin cancer	3.88e-05	0.000262	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—BRAF—skin cancer	3.76e-05	0.000254	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—BRAF—skin cancer	3.76e-05	0.000254	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—KRAS—skin cancer	3.72e-05	0.000251	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—TP53—skin cancer	3.65e-05	0.000247	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TERT—skin cancer	3.63e-05	0.000246	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TERT—skin cancer	3.58e-05	0.000242	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TERT—skin cancer	3.57e-05	0.000241	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—KRAS—skin cancer	3.51e-05	0.000237	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TERT—skin cancer	3.5e-05	0.000237	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—HRAS—skin cancer	3.49e-05	0.000236	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—NRAS—skin cancer	3.49e-05	0.000236	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—NRAS—skin cancer	3.47e-05	0.000234	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—HRAS—skin cancer	3.45e-05	0.000233	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—KRAS—skin cancer	3.44e-05	0.000233	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—KRAS—skin cancer	3.44e-05	0.000233	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—HRAS—skin cancer	3.42e-05	0.000231	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—HRAS—skin cancer	3.35e-05	0.000226	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—NRAS—skin cancer	3.32e-05	0.000224	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—TP53—skin cancer	3.3e-05	0.000223	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—IL6—skin cancer	3.3e-05	0.000223	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—HRAS—skin cancer	3.3e-05	0.000223	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—BRAF—skin cancer	3.28e-05	0.000222	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—IL6—skin cancer	3.27e-05	0.000221	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—BRAF—skin cancer	3.26e-05	0.00022	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TERT—skin cancer	3.25e-05	0.00022	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—IL6—skin cancer	3.21e-05	0.000217	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—HRAS—skin cancer	3.16e-05	0.000214	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—IL6—skin cancer	3.15e-05	0.000213	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—BRAF—skin cancer	3.12e-05	0.000211	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—TP53—skin cancer	3.12e-05	0.000211	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—NRAS—skin cancer	3.06e-05	0.000207	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ENO2—skin cancer	3.04e-05	0.000206	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—IL6—skin cancer	3.02e-05	0.000204	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—NRAS—skin cancer	3.01e-05	0.000204	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—NRAS—skin cancer	3.01e-05	0.000203	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—KRAS—skin cancer	3e-05	0.000203	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—KRAS—skin cancer	2.99e-05	0.000202	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—HRAS—skin cancer	2.98e-05	0.000201	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—NRAS—skin cancer	2.95e-05	0.000199	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—HRAS—skin cancer	2.93e-05	0.000198	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—HRAS—skin cancer	2.93e-05	0.000198	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—BRAF—skin cancer	2.88e-05	0.000195	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—KRAS—skin cancer	2.86e-05	0.000193	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—IL6—skin cancer	2.85e-05	0.000193	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—BRAF—skin cancer	2.83e-05	0.000191	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—BRAF—skin cancer	2.83e-05	0.000191	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—IL6—skin cancer	2.8e-05	0.000189	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—IL6—skin cancer	2.8e-05	0.000189	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—NRAS—skin cancer	2.78e-05	0.000188	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—BRAF—skin cancer	2.77e-05	0.000187	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—NRAS—skin cancer	2.76e-05	0.000187	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—NRAS—skin cancer	2.74e-05	0.000185	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—ERCC2—skin cancer	2.7e-05	0.000183	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—NRAS—skin cancer	2.7e-05	0.000183	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—NRAS—skin cancer	2.66e-05	0.00018	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—KRAS—skin cancer	2.64e-05	0.000178	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—KRAS—skin cancer	2.59e-05	0.000175	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—KRAS—skin cancer	2.59e-05	0.000175	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—BRAF—skin cancer	2.58e-05	0.000174	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—HRAS—skin cancer	2.55e-05	0.000172	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—KRAS—skin cancer	2.54e-05	0.000172	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—HRAS—skin cancer	2.54e-05	0.000172	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PTGS2—skin cancer	2.49e-05	0.000168	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—IL6—skin cancer	2.44e-05	0.000165	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—HRAS—skin cancer	2.43e-05	0.000164	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—IL6—skin cancer	2.43e-05	0.000164	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—KRAS—skin cancer	2.4e-05	0.000162	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—KRAS—skin cancer	2.38e-05	0.000161	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—NRAS—skin cancer	2.36e-05	0.00016	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—NRAS—skin cancer	2.36e-05	0.00016	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—KRAS—skin cancer	2.36e-05	0.000159	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—KRAS—skin cancer	2.33e-05	0.000157	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—IL6—skin cancer	2.33e-05	0.000157	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—KRAS—skin cancer	2.29e-05	0.000155	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—HRAS—skin cancer	2.24e-05	0.000151	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—HRAS—skin cancer	2.2e-05	0.000149	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—HRAS—skin cancer	2.2e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HRAS—skin cancer	2.16e-05	0.000146	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL6—skin cancer	2.14e-05	0.000145	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TP53—skin cancer	2.13e-05	0.000144	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TP53—skin cancer	2.11e-05	0.000143	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL6—skin cancer	2.11e-05	0.000143	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL6—skin cancer	2.1e-05	0.000142	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TP53—skin cancer	2.07e-05	0.00014	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL6—skin cancer	2.07e-05	0.00014	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—NRAS—skin cancer	2.06e-05	0.000139	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—NRAS—skin cancer	2.05e-05	0.000139	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HRAS—skin cancer	2.04e-05	0.000138	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TP53—skin cancer	2.04e-05	0.000138	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—KRAS—skin cancer	2.03e-05	0.000138	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—KRAS—skin cancer	2.03e-05	0.000138	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HRAS—skin cancer	2.02e-05	0.000137	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HRAS—skin cancer	2.01e-05	0.000136	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HRAS—skin cancer	1.98e-05	0.000134	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—NRAS—skin cancer	1.96e-05	0.000133	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL6—skin cancer	1.95e-05	0.000132	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HRAS—skin cancer	1.95e-05	0.000132	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL6—skin cancer	1.93e-05	0.000131	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL6—skin cancer	1.92e-05	0.00013	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL6—skin cancer	1.89e-05	0.000128	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL6—skin cancer	1.86e-05	0.000126	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—NRAS—skin cancer	1.81e-05	0.000122	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TP53—skin cancer	1.81e-05	0.000122	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TP53—skin cancer	1.81e-05	0.000122	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—NRAS—skin cancer	1.78e-05	0.00012	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—NRAS—skin cancer	1.78e-05	0.00012	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—KRAS—skin cancer	1.77e-05	0.00012	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ERCC2—skin cancer	1.77e-05	0.00012	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—KRAS—skin cancer	1.76e-05	0.000119	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—NRAS—skin cancer	1.74e-05	0.000118	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HRAS—skin cancer	1.73e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HRAS—skin cancer	1.73e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—KRAS—skin cancer	1.69e-05	0.000114	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL6—skin cancer	1.66e-05	0.000112	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL6—skin cancer	1.66e-05	0.000112	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTGS2—skin cancer	1.62e-05	0.00011	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—NRAS—skin cancer	1.62e-05	0.000109	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TP53—skin cancer	1.58e-05	0.000107	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TP53—skin cancer	1.57e-05	0.000106	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—KRAS—skin cancer	1.56e-05	0.000105	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—KRAS—skin cancer	1.53e-05	0.000104	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—KRAS—skin cancer	1.53e-05	0.000103	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HRAS—skin cancer	1.51e-05	0.000102	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TP53—skin cancer	1.5e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—KRAS—skin cancer	1.5e-05	0.000101	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HRAS—skin cancer	1.5e-05	0.000101	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL6—skin cancer	1.44e-05	9.75e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HRAS—skin cancer	1.44e-05	9.7e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL6—skin cancer	1.44e-05	9.7e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—KRAS—skin cancer	1.39e-05	9.42e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TP53—skin cancer	1.38e-05	9.35e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL6—skin cancer	1.37e-05	9.28e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TP53—skin cancer	1.36e-05	9.2e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TP53—skin cancer	1.36e-05	9.18e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TP53—skin cancer	1.33e-05	9.01e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HRAS—skin cancer	1.32e-05	8.94e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HRAS—skin cancer	1.3e-05	8.8e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HRAS—skin cancer	1.3e-05	8.78e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HRAS—skin cancer	1.27e-05	8.62e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL6—skin cancer	1.27e-05	8.56e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL6—skin cancer	1.25e-05	8.42e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL6—skin cancer	1.24e-05	8.4e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TP53—skin cancer	1.24e-05	8.37e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL6—skin cancer	1.22e-05	8.25e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HRAS—skin cancer	1.18e-05	8.01e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL6—skin cancer	1.13e-05	7.66e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTGS2—skin cancer	1.06e-05	7.17e-05	CbGpPWpGaD
